AIDS Malignancy Consortium
AIDS Malignancy Consortium
Explore linked clinical trials.11 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Not yet recruiting | Phase 2 | 2026-10-05 | NCT07662928 | |
| A Study of Propranolol to Treat Kaposi Sarcoma | DNA Virus Infections, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma, vascular cancer, viral infectious disease | Recruiting | Phase 2 | 2026-10-05 | NCT05797662 | |
| Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-08-19 | NCT04949464 | |
| Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma | B-cell neoplasm, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, RNA Virus Infections, Urogenital Diseases, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, lentivirus infection, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 1 | 2026-07-10 | NCT05077527 | |
| Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers | B-cell neoplasm, Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Multi-centric Castleman's Disease, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, RNA Virus Infections, Urogenital Diseases, anal carcinoma, anus disorder, anus neoplasm, colorectal neoplasm, diffuse large B-cell lymphoma, digestive system disorder, digestive system neoplasm, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, intestinal disorder, lentivirus infection, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, multicentric Castleman disease, neoplasm, plasmablastic lymphoma, rectal disorder, rectal neoplasm, sarcoma, sexually transmitted disease, uterine carcinosarcoma, vascular cancer, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-06-01 | NCT05663502 | |
| A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, plasmablastic lymphoma | Recruiting | Early phase 1 | 2026-06-01 | NCT04139304 | |
| Nirogacestat in Patients With Kaposi Sarcoma | AIDS-related Kaposi sarcoma | Not yet recruiting | Phase 2 | 2026-05-28 | NCT07539454 | |
| Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant | B-cell neoplasm, Blood-Borne Infections, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Neoplasms by Histologic Type, RNA Virus Infections, T-cell non-Hodgkin lymphoma, Tumor Virus Infections, Urogenital Diseases, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, lentivirus infection, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm, plasmablastic lymphoma, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-18 | NCT02797470 | |
| Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa | ocular surface squamous neoplasia | Recruiting | Not applicable | 2026-03-23 | NCT04704648 | |
| Trial of Ixazomib for Kaposi Sarcoma | DNA Virus Infections, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma, vascular cancer, viral infectious disease | Recruiting | Phase 2 | 2026-02-27 | NCT04305691 | |
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma | AIDS, AIDS-related Kaposi sarcoma, Blood-Borne Infections, DNA Virus Infections, Genital Diseases, HIV infectious disease, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, neoplasm, sarcoma, sexually transmitted disease, uterine carcinosarcoma, vascular cancer, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 3 | 2026-01-23 | NCT05411237 |